Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2025
Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68-week randomized Phase 3 trialMasamoto Murakami, Yukari Okubo, Satomi Kobayashi, et al.
The Journal of Investigative Dermatology|June 10, 2011
Transcriptional inhibition of hypertrophic scars by a gene silencer, pyrrole-imidazole polyamide, targeting the TGF-β1 promoterHisayo Washio, Noboru Fukuda, Hiroyuki Matsuda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12Hidekazu Shirota, Kunio Sano, Noriyasu Hirasawa, et al.
European Journal of Immunology|October 26, 2005
Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation modelTanawatt Kootiratrakarn, Taku Fujimura, Kunio Sano, et al.
JAMA Dermatology|July 4, 2019
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical TrialTadashi Terui, Satomi Kobayashi, Yukari Okubo, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 8, 2015
The oncogenic role of GASC1 in chemically induced mouse skin cancerYumi Ozaki, Kyoko Fujiwara, Maki Ikeda, et al.
Indian Journal of Dermatology|November 6, 2015
Autoantibodies Against Multiple Epitopes in Bp180 and Laminin Gamma-1 in Subepidermal Blistering Skin Disease Associated with Psoriatic ErythrodermaHaruna Goto-Hamano, Keiko Ito, Kumiko Sakamoto-Kimura, et al.
Asia Pacific Allergy|May 16, 2020
Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticariaTakahiro Endo, Shota Toyoshima, Koremasa Hayama, et al.
The Journal of Dermatology|June 2, 2023
Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52-week analysis of a postmarketing surveillance study in JapanNobukazu Hayashi, Koremasa Hayama, Kenzo Takahashi, et al.
The Journal of Dermatology|October 25, 2020
Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real-world evidence in JapanHideki Fujita, Mamitaro Ohtsuki, Akimichi Morita, et al.
Pageof 9